Literature DB >> 12071778

Statistical techniques for signal generation: the Australian experience.

Patrick Purcell1, Simon Barty.   

Abstract

National voluntary reporting systems generate large volumes of clinical data pertinent to drug safety. Currently descriptive statistical techniques are used to assist in the detection of drug safety 'signals'. Australian data have been coded according to guidelines formulated almost 30 years ago and which have resulted in many drugs which are not associated with an adverse drug reaction or 'innocent bystander' drugs being recorded as 'suspected' in individual reports. In this paper we explore the application of an iterative probability filtering algorithm titled 'PROFILE'. This serves to identify the 'signals' and remove the 'innocent bystander' drugs, thus providing a clearer view of the drugs most likely to have caused the reactions. Reaction terms analysed include neutropenia, agranulocytosis, hypotension, hypertension, myocardial infarction, neuroleptic malignant syndrome, and rectal haemorrhage. In this version of PROFILE, Fishers exact test has been used as the statistical tool but other methods could be used in future. Advantages and limitations of the method and its assumptions are discussed together with the rationale underlying the method and suggestions for further enhancements.

Entities:  

Mesh:

Year:  2002        PMID: 12071778     DOI: 10.2165/00002018-200225060-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  3 in total

1.  From association to alert--a revised approach to international signal analysis.

Authors:  M Lindquist; I R Edwards; A Bate; H Fucik; A M Nunes; M Ståhl
Journal:  Pharmacoepidemiol Drug Saf       Date:  1999-04       Impact factor: 2.890

Review 2.  Principles of signal detection in pharmacovigilance.

Authors:  R H Meyboom; A C Egberts; I R Edwards; Y A Hekster; F H de Koning; F W Gribnau
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

3.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

  3 in total
  6 in total

Review 1.  Quantitative methods in pharmacovigilance: focus on signal detection.

Authors:  Manfred Hauben; Xiaofeng Zhou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Risk management from an Asian/Pacific Rim regulatory perspective.

Authors:  John McEwen
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Perspectives on the use of data mining in pharmaco-vigilance.

Authors:  June Almenoff; Joseph M Tonning; A Lawrence Gould; Ana Szarfman; Manfred Hauben; Rita Ouellet-Hellstrom; Robert Ball; Ken Hornbuckle; Louisa Walsh; Chuen Yee; Susan T Sacks; Nancy Yuen; Vaishali Patadia; Michael Blum; Mike Johnston; Charles Gerrits; Harry Seifert; Karol Lacroix
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  A model for decision support in signal triage.

Authors:  Bennett Levitan; Chuen L Yee; Leo Russo; Richard Bayney; Adrian P Thomas; Stephen L Klincewicz
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  A distributed, collaborative intelligent agent system approach for proactive postmarketing drug safety surveillance.

Authors:  Yanqing Ji; Hao Ying; Margo S Farber; John Yen; Peter Dews; Richard E Miller; R Michael Massanari
Journal:  IEEE Trans Inf Technol Biomed       Date:  2009-12-11

6.  Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams.

Authors:  Ryan Eshleman; Rahul Singh
Journal:  BMC Bioinformatics       Date:  2016-10-06       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.